US Patent Issued to The Trustees of Columbia University in the City of New York, The Regents of the University of California on Sept. 30 for "Dominant negative CEBPB and CEBPD proteins and methods of use for decreasing viability of neoplastic cells" (New York, New Jersey, California Inventors)

ALEXANDRIA, Va., Sept. 30 -- United States Patent no. 12,428,455, issued on Sept. 30, was assigned to The Trustees of Columbia University in the City of New York (New York) and The Regents of the University of California (Oakland, Calif.).

"Dominant negative CEBPB and CEBPD proteins and methods of use for decreasing viability of neoplastic cells" was invented by Lloyd A. Greene (Larchmont, N.Y.), Xiaotian Sun (Fort Lee, N.J.) and James M. Angelastro (David, Calif.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Dominant negative forms of CEBPB and CEBPD, and cell-penetrating forms thereof are described. Methods for using the dominant negative forms of CEBPB and CEBPD proteins, and cell-penetrating forms there...